Eponyms in Oncology: Zollinger-Ellison Syndrome
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
Researchers found that, in 18% of recurrences, the new tumor was molecularly unrelated to the original tumor.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Waldenström macroglobulinemia.
Patients who have mismatch repair proficiency in the primary setting may have mismatch repair deficiency at recurrence.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Sister Mary Joseph nodule.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Trousseau’s sign of malignancy.